| Keyword | CPC | PCC | Volume | Score |
|---|---|---|---|---|
| nejm head and neck cancer | 0.92 | 0.1 | 9227 | 1 |
| pembrolizumab head and neck cancer nejm | 1.6 | 0.3 | 8903 | 11 |
| head and neck cancer review nejm | 1.23 | 1 | 7097 | 62 |
| head and neck cancer pubmed | 1.04 | 0.1 | 4440 | 69 |
| head and neck cancer nih | 0.78 | 0.5 | 7986 | 94 |
| head and neck cancer journal articles | 1.75 | 0.4 | 891 | 68 |
| head and neck cancer journals | 0.42 | 1 | 7086 | 60 |
| head and neck cancer ncbi | 0.29 | 0.4 | 4767 | 91 |
| cancer research uk head and neck cancer | 1.45 | 0.1 | 5615 | 47 |
| head and neck cancer research | 1.6 | 0.4 | 2037 | 37 |
| head and neck cancer patient | 1.96 | 0.4 | 6900 | 21 |
| head and neck cancer epidemiology | 0.72 | 0.4 | 8814 | 85 |
| neck and head cancer | 0.68 | 0.1 | 5935 | 47 |
| suspected head and neck cancer | 1.16 | 0.1 | 4500 | 43 |
| cdc head and neck cancer | 1.93 | 0.7 | 3529 | 50 |
| head and neck cancer review | 0.54 | 0.1 | 9715 | 90 |
| head and neck cancer clinical trials | 1.19 | 0.3 | 2134 | 82 |
| head and neck cancer pathology | 1.44 | 0.2 | 8892 | 35 |
| head and neck cancer outcomes | 1.23 | 0.1 | 614 | 87 |
